The National Comprehensive Cancer Network has released a free resource to help patients with acute myeloid leukemia and their families become better informed in treatment decision-making. READ MORE
The treatment of mantle cell lymphoma carries a significant economic burden in the real-world setting, according to research presented at the ASH Annual Meeting & Exposition.
Maintenance therapy with a specific drug is associated with superior OS and PFS in patients who receive high-dose therapy followed by ASCT for MCL.
The US Food and Drug Administration has expanded the indication for a drug to treat previously untreated follicular lymphoma.
Jennifer R Brown, MD, PhD, presented the emerging treatments and management options for front line and relapsed or refractory chronic lymphocytic leukemia today at the Clinical Pathways Congress.